The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis.

Saraff V, Sancho PA, Bacchetta J, Boot AM, Burren C, Chinoy A, Dharmaraj P, Llorente MAG, Rodríguez JDG, Gueorguieva I, Davies EH, Hayes W, Komarzynski S, Duro HR, Rylands AJ, Sandilands K, Williams A, Hardie E, Ishii H, Schnabel D, Selveindran SM, Linglart A

Open source

DOI: 10.1371/journal.pone.0344902
Published: 2026
Container: PloS one
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0344902,
  title = {The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis.},
  author = {Saraff V and Sancho PA and Bacchetta J and Boot AM and Burren C and Chinoy A and Dharmaraj P and Llorente MAG and Rodríguez JDG and Gueorguieva I and Davies EH and Hayes W and Komarzynski S and Duro HR and Rylands AJ and Sandilands K and Williams A and Hardie E and Ishii H and Schnabel D and Selveindran SM and Linglart A},
  year = {2026},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0344902},
  url = {https://doi.org/10.1371/journal.pone.0344902}
}

RIS

TY  - JOUR
TI  - The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis.
AU  - Saraff V
AU  - Sancho PA
AU  - Bacchetta J
AU  - Boot AM
AU  - Burren C
AU  - Chinoy A
AU  - Dharmaraj P
AU  - Llorente MAG
AU  - Rodríguez JDG
AU  - Gueorguieva I
AU  - Davies EH
AU  - Hayes W
AU  - Komarzynski S
AU  - Duro HR
AU  - Rylands AJ
AU  - Sandilands K
AU  - Williams A
AU  - Hardie E
AU  - Ishii H
AU  - Schnabel D
AU  - Selveindran SM
AU  - Linglart A
PY  - 2026
JO  - PloS one
DO  - 10.1371/journal.pone.0344902
UR  - https://doi.org/10.1371/journal.pone.0344902
ER  -

APA

V, S., PA, S., J, B., AM, B., C, B., A, C., P, D., MAG, L., JDG, R., I, G., EH, D., W, H., S, K., HR, D., AJ, R., K, S., A, W., E, H., H, I., D, S., SM, S., & A, L. (2026). The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis.. PloS one. https://doi.org/10.1371/journal.pone.0344902

Source records

pubmed · retrieved 2026-09-26T19:12:07.488Z